Suven Pharma and Cohance Lifesciences Announce Merger, Signaling Strategic Shift in Pharmaceutical Sector
The merger between Suven Pharma and Cohance Lifesciences is anticipated to be finalized within the next 12-15 months, pending the necessary approvals from shareholders and regulatory authorities. This timeline underscores the meticulous process required to solidify the transaction and reflects the companies’ commitment to ensuring a seamless transition. Stay tuned as both entities navigate through … Read more